OPR - Delayed Quote • USD LAB May 2024 2.500 call (SLGC240517C00002500) Follow 0.2900 0.0000 (0.00%) At close: January 4 at 2:56 PM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for SLGC240517C00002500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: LAB Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)? Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB) Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript Standard BioTools Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line Q4 2023 Standard BioTools Inc Earnings Call Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ...
